Nalaganje...
Loss of immune tolerance to IL-2 in type 1 diabetes
Type 1 diabetes (T1D) is characterized by a chronic, progressive autoimmune attack against pancreas-specific antigens, effecting the destruction of insulin-producing β-cells. Here we show interleukin-2 (IL-2) is a non-pancreatic autoimmune target in T1D. Anti-IL-2 autoantibodies, as well as T cells...
Shranjeno v:
| izdano v: | Nat Commun |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5059699/ https://ncbi.nlm.nih.gov/pubmed/27708334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ncomms13027 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|